Vaccination is a promising tool for malaria control. The RTS,S/AS01 (Mosquirix) malaria vaccine is the first and, as of now, the only vaccine to show partial protection against malaria in young children. It is currently being piloted in several African countries, with the goal of assessing its impact on malaria morbidity and mortality. Continued research and development are essential to improve vaccine efficacy and coverage.
